The market growth of Cell Culture rising advancement of proteomic gene expression andconsequent development of novel vaccine and biopharmaceuticals is currently driving thedemand cell cultures techniques over the forecast period. Further increase in the number of cancer research projects and enhanced applications of gene therapies are also factors expected to drive the cell culture market demand over the forecast period.
Owing to the cost and investment involved in setting up cell culture technology infrastructure, the number of contract research and manufacturing is growing. Also, cumulative incidences of chronic diseases have led to increase in cell biology & cytological studies and associated research resulting in the cell culture marketgrowth.
The Encouraging factors rising the demand for biopharmaceuticals have the better efficacy and accident injuries which is more effectively than pharmaceutical medicines.
The another major factor which is increasing in demandforbiopharmaceuticals inpersonalized medicine is rising the production of biopharmaceutical medicines in smaller batch sizes which is a promising element for personalized treatment.
The adoption of single-use technologies has increased owing to the benefits over traditional stainless-steel bioreactors such as low contamination risk and cost-effectiveness along with the benefits of single-use bioreactors.
The sera, media, and reagents segment are expected to account for the largest share of the cell culture consumables markets attributed to the repeated purchase of sera, media, and reagents for various cell culture applications such as biopharmaceutical production, vaccine production, toxicology, and drug discovery.
The highest growth among these segments is being observed in the media market, the cell culture market is driven by increasing vertical integration, growth of the biopharmaceutical industry owing to increasing demand and preference for alternative media.
Many vendors areintensively focusing on research to introduce innovative 3D cell culture systems for customers. Forexample, Thermo Fisher introduced AlgiMatrix 3D Culture System for research fields, such astoxicology, drug development, cancer research, and tissue engineering.
Due to their broadrange of application in several areas including biopharmaceuticals production, and academicand laboratory research the demand for serum-free and customized media solutions is very high.
Serum-free media is the fastest growing segment dueto its high demand in the Pharmaceutical and Biotechnology industries, because of contaminationthe Biopharmaceutical industry faces the risk of production failure.
Cell culture automation systems are penetrating market growth in mAb production, iPSC research,cryobanking, cell-based assays, and cellular expression systems as they save time and reducecontamination risk.
Advancements in technology inAutomated cell culture systems have resulted in high demand for the rapidproduction and selection of optimized cell lines, predominantly for high-throughput, andcell-basedscreening applications.
Further, Automated cell culture systems also minimize the risk ofcontamination and create much higher productivity within a short period than the traditionaltechnique of cell culturing.
North America is dominating for the largest market share due to the growing regulatory approvals for cell culture-based vaccines.
Technological advancements, growth in the biotechnology and pharmaceutical industries, and others are the key factors driving the growth of the cell culture market in North America.
Development of animal-component free media and presence of novel automated cell culture systems reducing the lag times and enhancing the production capacity of entire projects are some factors expected to enhance the demand for cell culture techniques over the forecast period.
Becton, Dickinson and Company, Thermo Fisher Scientific, Merck KGaA, HiMedia Laboratories, GE Healthcare, Lonza, Corning Incorporated, Sartorius AG, Eppendorf AG, PromoCell GmbH, Danaher Corporation, Irvine Scientific, InvivoGen, CellGenix GmbH.
In 2019, update of a next-level innovation in single-use bioreactors byThe Thermo Scientific , a Single-英雄联盟竞猜比赛4.10.1e Bioreactor (S.U.B.) called HyPerforma DynaDrive is thelatest innovation in single-use bioreactors, continuing the success of the robust HyPerforma bioreactors first launched in 2006 and updated in 2013.
This new design provides improved performance and scalability to larger volumes.HyPerforma DynaDrive S.U.B. ensuresthe optimal cell culture by performing across all scales and increased cell densities.
Lonza Group, hugely invests and delivers a wide range of cell culture products and technology-induced development to boost the cellular and pharmaceutical research study.
Its major contribution to the cell culture market includes RAFT™ 3D Cell Culture System and Quasi Vivo® 3D Cell Culture System to produce 3D models for promoting cell line construction, monoclonal antibodies and other genetically engineered protein development.
Cell Counting Market, Size, Share, Outlook and Growth Opportunities 2019-2025
Stem Cell Market, Size, Share, Outlook and Growth Opportunities 2019-2025